Publications
ARTICLE Kim M. Stegmann et al.
ARTICLE Elizabeth J. Carey, John Eaton, Mitchell Clayton, Andrea Gossard, Sara Iqbal, Hamid Ullah, Nan Zhang, Richard Butterfield, Keith D. Lindor
POSTER PRESENTATION Wednesday, February 16, 2022 – Saturday, February 19, 2022
PRESENTATION Tuesday, December 14, 2021
POSTER PRESENTATION Wednesday, October 13, 2021 – Friday, October 15, 2021
PRESENTATION Wednesday, October 6, 2021
POSTER PRESENTATION Wednesday, September 22, 2021 – Saturday, September 25, 2021
PRESENTATION Monday, July 12, 2021
POSTER PRESENTATION Wednesday, June 30, 2021 – Saturday, July 3, 2021
PRESENTATION Thursday, July 1, 2021
POSTER PRESENTATION Saturday, April 17, 2021 – Thursday, April 22, 2021
POSTER PRESENTATION Wednesday, March 24, 2021 – Friday, March 26, 2021
PRESENTATION February 18, 2021
ARTICLE Andreas Muehler, Jason R. Slizgi, Hella Kohlhof, Manfred Groeppel, Evelyn Peelen, Daniel Vitt
ARTICLE Friedrich Hahn, Christina Wangen, Sigrun Häge, Antonia Sophia Peter, Gerhard Dobler, Brett Hurst, Justin Julander, Jonas Fuchs, Zsolt Ruzsics, Klaus Überla, Hans-Martin Jäck, Roger Ptak, Andreas Muehler, Manfred Gröppel, Daniel Vitt, Evelyn Peelen, Hella Kohlhof, Manfred Marschall
POSTER PRESENTATION Friday, September 11, 2020 – Sunday, September 13, 2020
PRESENTATION Friday, September 11, 2020
PRESENTATION Monday, August 3, 2020
ARTICLE Yu-Jin Kim, Beatrice Cubitt, Yingyun Cai, Jens H. Kuhn, Daniel Vitt, Hella Kohlhof, Juan C. de la Torre
PRESENTATION Tuesday, May 19, 2020
ARTICLE Andreas Muehler, Evelyn Peelen, Hella Kohlhof, Manfred Gröppel, Daniel Vitt
ARTICLE Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel Vitt
ABSTRACT Robert Fox, Heinz Wiendl, Nicola De Stefano, Johann Sellner, Andreas Mühler
PRESENTATION Wednesday, December 4, 2019
POSTER PRESENTATION Tuesday, October 22, 2019
ARTICLE Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel Vitt
POSTER PRESENTATION Wednesday, September 11, 2019
PRESENTATION Monday, June 24, 2019
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
iScience
Published: May 20, 2022
https://doi.org/10.1016/j.isci.2022.104293
A Pilot Study of Vidofludimus Calcium for Treatment of Primary Sclerosing Cholangitis
Hepatology Communications
Published: March 3, 2022
https://doi.org/10.1002/hep4.1926
17th Congress of ECCO (European Crohn’s and Colitis Organization)
IMU-935: Phase 1 SAD/MAD Data in Healthy Human Subjects and Preclinical Update
Play Audio Recording
37th Congress of European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
B&T Cell-Mediated Autoimmune Disease Drug Development Summit
50th Annual European Society for Dermatological Research (ESDR) Meeting
Virtual R&D Day: Update on the Preclinical and Clinical Development of IMU-935
Play Audio Recording
The International Federation of Psoriasis Association’s 6th World Psoriasis & Psoriatic Arthritis Conference 2021
IMU-838 in Multiple Sclerosis: Phase 3 Program in RRMS & Phase 2 Trial in PMS
Play Audio Recording
2021 Virtual AAN Annual Meeting
Play Audio Recording
30th Annual Meeting of the Society for Virology
Main Phase 2 Analysis IMU-838 in Moderate COVID-19 & Phase 2 Proof-of-Concept Study IMU-838 in PSC
Play Audio Recording
Clinical Relevance of Intestinal Barrier Dysfunction in Common Gastrointestinal Diseases
World Journal of Gastrointestinal Pathophysiology
Published: December 12, 2020
https://doi.org/10.4291/wjgp.v11.i6.114
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro
Viruses
Published: December 5, 2020
https://doi.org/10.3390/v12121394
MSVirtual2020 / 8th Joint ACTRIMS-ECTRIMS Meeting
IMU-838 Phase 2 Data EMPhASIS Trial in RRMS
Play Audio Recording
IMU-838 Phase 2 Top-Line Data EMPhASIS Trial in RRMS
Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity Against Mammarenaviruses In Vitro
Viruses
Published: July 29, 2020
https://doi.org/10.3390/v12080821
Immunic’s Inaugural Virtual R&D Day
Play Audio Recording
Vidofludimus Calcium, a Next Generation DHODH Inhibitor for the Treatment of Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis and Related Disorders
Published: May 6, 2020
https://doi.org/10.1016/j.msard.2020.102129
Safety, Tolerability and Pharmacokinetics of Vidofludimus Calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects
European Journal of Drug Metabolism and Pharmacokinetics
Published: May 2, 2020
https://doi.org/10.1007/s13318-020-00623-7
Design, Rationale and Baseline Characteristics of the Randomized Double-blind Phase II Clinical Trial of Vidofludimus calcium (IMU-838) in Relapsing-Remitting Multiple Sclerosis (4558)
Neurology
Published: April 14, 2020
IBD Innovate Conference: Product Development for Crohn’s and Colitis
New York
United European Gastroenterology Week (UEGW)
Barcelona, Spain
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study
Drugs in R&D
Published: October 16, 2019
https://doi.org/10.1007/s40268-019-00286-z
Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2019
Stockholm, Sweden
GI Inflammatory Diseases Summit (GIIDS)
Boston
.